LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Clinical trials for LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG explained in plain language.
Never miss a new study
Get alerted when new LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG trials appear
Sign up with your email to follow new studies for LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New triple therapy targets rare neuroendocrine cancers in first-line trial
Disease control Not yet recruitingThis study tests a combination of three drugs (benmelstobart, anlotinib, and chemotherapy) as the first treatment for people with a rare and aggressive type of lung cancer called large-cell neuroendocrine carcinoma, as well as similar cancers outside the lung. The goal is to see …
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New hope for rare lung cancer: drug combo targets tough tumors
Disease control Not yet recruitingThis study tests whether adding a new drug called obrixtamig to standard chemotherapy can help people with advanced large-cell neuroendocrine carcinoma of the lung, a rare and aggressive cancer. About 75 adults who have not yet started or have only had one round of chemo will rec…
Matched conditions: LARGE CELL NEUROENDOCRINE CARCINOMA OF THE LUNG
Phase: PHASE2 • Sponsor: Technische Universität Dresden • Aim: Disease control
Last updated May 13, 2026 16:04 UTC